Third International Conference AI_4_LIFE: Biotech Future Forum Opens in Belgrade

The conference brings together more than 1,000 participants from over 15 countries and 66 international speakers, including government representatives, scientists, academics, and leaders from the business sector.

“We are here to explore the latest achievements in artificial intelligence and biotechnology—two fields that are undoubtedly shaping our future. As a scientist and someone deeply passionate about technology, I believe we are living in extraordinary times. We are not only witnessing technological transformation but also fundamental changes in our lifestyles, societies, and even in our evolution as a species,” said Dr. Jelena Begović, Minister of Science, Technological Development, and Innovation, during the conference opening.

Dr. Begović emphasized the accelerating pace of technological advancement: “We live in the era of the Fourth Industrial Revolution, where innovation defines every aspect of our lives. The question we must ask is: Are we ready to lead these changes or merely observe from the sidelines? Serbia has chosen not only to participate but to lead. Our commitment to innovation is clear through initiatives like the BIO4 Campus, which aims to position Serbia as a key European and global center for biotechnology.”

Opening remarks were also delivered by Mirek Dušek from the World Economic Forum and Ivana Živković, UN Assistant Secretary-General and Director of UNDP for Europe and the Commonwealth of Independent States. The distinguished lineup of participants includes globally recognized experts, such as Dr. Christopher Voigt, Head of the Department of Biological Engineering at MIT, and Dr. George Yancopoulos, founder of Regeneron, a leading company in modern pharmaceuticals.

The conference addresses topics including national strategies for the development and application of artificial intelligence, along with its impact on healthcare, agriculture, and environmental protection. Special focus is given to big data processing, genetic innovations, and emerging healthcare opportunities increasingly driven by biotechnology and artificial intelligence.